🟢 Senti Biosciences is trading 6% up in after-hours trading after disclosing $2 million third note tranche

Senti Biosciences is trading 6% up at $0.36 in after-hours trading after disclosing a newly authorized $2 million third tranche of senior secured convertible notes.

• The financing may have supported the after-hours gain.
• The announcement highlighted Nasdaq notices concerning minimum bid price and stockholders’ equity requirements.
• The company received until February 23, 2027, to regain bid-price compliance.